- Genomic Health Inc.
- Genoptix Inc.
- Novartis AG
- Clarient Inc.
- GE Healthcare
- General Electric Co.
- Abbott Laboratories Inc.
- Nodality Inc.
- BioMarker Strategies LLC
- On-Q-ity Inc.
- Johnson & Johnson
- Janssen Diagnostics LLC
- Massachusetts General Hospital
- Illumina Inc.
- Qiagen NV
- AstraZeneca PLC
- Ortho Biotech Oncology Research & Development
- Siemens AG
- Quanterix Corp.
- Ventana Medical Systems Inc.
- Laboratory Corp. of America Holdings
- Novartis Molecular Diagnostics
- Quest Diagnostics Inc.
- Celera Corp.
- Berkeley HeartLab Inc.
- Pfizer Inc.
- Abbott Molecular Inc.
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Novartis buys Genoptix for $440mm; Genoptix sold off
- GE to buy Clarient for $587mm
- Veridex, Mass Gen work on circulating tumor cell technology
- Qiagen buys DxS for $95mm plus earn-outs
- Chromos acquires Targeted Molecules Corp.
- Roche offers $75 cash/share for histopathology player Ventana
- Quest Diagnostics buys Celera
- Abbott to develop companion Dx for Pfizer's NSCLC candidate
- GSK signs second MAGE-A3 collaboration with Abbott Molecular
- Abbott, GSK to develop diagnostic for NSCLC
- Roche to create companion test for Clovis’ CO1686
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.